Abstract
Anti-thymocyte globulin (ATG) induction therapy is supposed to reduce the incidence of acute cellular rejection (ACR), which is associated with inferior outcomes in lung transplantation (LTx). However, according to the different types and dosage of ATG, there is no consensus on its efficacy and safety. The aim of this study was to evaluate the effect of rabbit ATG induction on the incidence of ACR and infection complications during the first year after LTx.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
